1-11 of 11
Sara Barulli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact Project, a CML Campus Study

Elisabetta Abruzzese, Simona Bernardi, Uros Markovic, Malgorzata Monika Trawinska, Sara Barulli, Alessandro Maggi, Sara Galimberti, Cristina Bucelli, Daniele Sannipoli, Mariella D'Adda, Elena Chiara, Massimiliano Bonifacio, Antonella Russo Rossi, Germana Beltrami, Sabina Russo, Elena Crisa', Grazia Sanpaolo, Francesco Cavazzini, Giuseppina Loglisci, Carmen Fava, Federica Maria Catania, Anna Rita Scortechini, Barbara Scappini, Giovanna Rege Cambrin, Gianni Binotto, Monica Bocchia, Davide Facchinelli, Ambra Di Veroli, Sara Pasquina Pascale, Annapaola Leporace, Matia Bernardi, Monica Crugnola
Journal: Blood
Blood (2024) 144 (Supplement 1): 4532.
https://doi.org/10.1182/blood-2024-211476
Published: 2024
Journal Articles

First-Line Treatment with Nilotinib in Chronic Myeloid Leukemia Patients in Real-Life: Results of the Observational Study Gimema CML0912

Gabriele Gugliotta, MD PhD, Fausto Castagnetti, MD, Francesca Lunghi, MD, Serena Rupoli, MD, Elisabetta Abruzzese, MD, Massimo Breccia, MD PhD, Alessandra Iurlo, MD PhD, Bruno Martino, Patrizia Pregno, MD, Mario Tiribelli, MD, Giovanna Rege Cambrin, Giuseppe Tagariello, Laura Nocilli, Antonietta Pia Falcone, MD, Debora Luzi, Monica Crugnola, MD, Sara Barulli, MD, Massimiliano Bonifacio, MD, Sabina Russo, Delia Noli, MD, Simona Soverini, PhD, Robin Foà, MD, Michele Cavo, MD, Giovanni Martinelli, MD, Fabrizio Pane, MD, Giuseppe Saglio, MD PhD, Michele Baccarani, MD, Gianantonio Rosti, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5253.
https://doi.org/10.1182/blood.V130.Suppl_1.5253.5253
Published: 2017
Journal Articles

Prognostic Impact of TS, MTHFR and XRCC1 Genetic Variants in 113 Patients with Myelodysplastic Syndromes

Federica Loscocco, PhD, Giuseppe Visani, MD, Elisa Giacomini, Annamaria Ruzzo, Sara Galimberti, MD, Maria Teresa Voso, MD PhD, Carlo Finelli, MD, Elena Ciabatti, Emiliano Fabiani, Francesco Graziano, Sara Barulli, Antonio Volpe, MD, Domenico Magro, Pier Paolo Piccaluga, MD PhD, Fabio Fuligni, Marco Vignetti, Paola Fazi, Alfonso Piciocchi, Cristina Clissa, MD, Elisa Gabucci, Marco Rocchi, Mauro Magnani, Alessandro Isidori, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1675.
https://doi.org/10.1182/blood.V126.23.1675.1675
Published: 2015
Journal Articles

The Mutational Status Of Genes Involved In DNA Repair and Folate Pathway Predicts Overall Survival Of Patients With Low-Risk, Untreated Myelodysplastic Syndrome

Alessandro Isidori, MD, PhD, Annamaria Ruzzo, PhD, Federica Loscocco, Maria Teresa Voso, M.D., Francesco Graziano, Sara Barulli, Emanuele Canestrari, Antonio Volpe, MD, Domenico Magro, MD, Pier Paolo Piccaluga, MD, PhD, Fabio Fuligni, Stefania Paolini, Teresa Ricciardi, Paola Picardi, Elisa Giacomini, Marco Rocchi, Mauro Magnani, Giuseppe Visani, MD
Journal: Blood
Blood (2013) 122 (21): 2815.
https://doi.org/10.1182/blood.V122.21.2815.2815
Published: 2013
Journal Articles

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

Giuseppe Visani, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Federica Loscocco, Pier Paolo Piccaluga, Fabio Fuligni, Anna Gazzola, PhD, Maura Rossi, Antonella Laginestra, Maria Rita Caraci, Cira Riccardi, Axel Visani, Sara Barulli, Barbara Guiducci, Teresa Ricciardi, Giovanni Sparaventi, Marco Rocchi, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 496.
https://doi.org/10.1182/blood.V122.21.496.496
Published: 2013
Journal Articles

LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY,

Giuseppe Visani, Felicetto Ferrara, MD, Francesco Di Raimondo, MD, Maria Rita Caraci, Tiziana Izzo, Sara Barulli, Barbara Guiducci, Federica Loscocco, Teresa Ricciardi, Giovanni Sparaventi, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3627.
https://doi.org/10.1182/blood.V118.21.3627.3627
Published: 2011
Journal Articles

Long Term Follow-up of Ph+ CML Patients Achieving Complete Cytogenetic Response (CCgR) with Interferon Based Therapy - GIMEMA Protocol CML0509

Domenico Russo, Giuliana Alimena, Chiara Colombi, Massimo Breccia, Simona Soverini, Ilaria Iacobucci, PhD, Federica Cattina, MD, Giovanni Martinelli, MD, Nicoletta Testoni, Anna Marina Liberati, Viviana Appolloni, Mario Tiribelli, Renato Fanin, Felicetto Ferrara, MD, Mario Annunziata, MD, Elena Trabacchi, Daniele Vallisa, MD, Antonio De Vivo, Fausto Castagnetti, Miriam Fogli, Sandra Durante, Francesco Di Raimondo, MD, Fabio Stagno, A. M. Carella, G. Pica, Alessandra Iurlo, M.D., Tommaso Radice, Patrizia Pregno, MD, Umberto Vitolo, MD, Elisabetta Abruzzese, Paolo de Fabritiis, Maurizio Longinotti, MD, Simonetta Pardini, Caterina Musolino, MD, Sabina Russo, Marco Gobbi, MD, Ivana Pierri, Gianluca Gaidano, Monia Lunghi, M.D., Giuseppe Visani, Sara Barulli, Mario Cazzola, Serena Merante, Cristina Skert, MD, Michele Malagola, Gianantonio Rosti, MD, Michele Baccarani, MD
Journal: Blood
Blood (2011) 118 (21): 786.
https://doi.org/10.1182/blood.V118.21.786.786
Published: 2011
Journal Articles

Analysis of Toxicity and Efficacy of Subcutaneous Cladribine at Reduced or Standard Doses (Five Versus Seven Consecutive Days) In Patients with Hairy Cell Leukemia (HCL) In the ICGHCL2004 Protocol by the Italian Cooperative Group on Hcl

Francesco Forconi, MD, Emanuele Cencini, Francesco Zaja, Tamara Intermesoli, Francesca Fiore, Benedetta Puccini, Caterina Stelitano, Renato Cantaffa, Alessandro Pulsoni, Alfonso Zaccaria, Pier Luigi Zinzani, MD, PhD, Andrea Piccin, MD, Filippo Gherlinzoni, MD, Alessandro Levis, MD, Giovanni Martinelli, MD, Sara Barulli, Fortunato Morabito, MD, Ivana Pierri, Miriana Ruggeri, Alessandra Caremani, Luciano Masini, Giuseppe Polimeno, Angelo Guerrasio, Elisa Sozzi, Davide Rossi, Piero Galieni, Marco Gobbi, MD, Sergio Cortelazzo, Luigi Rigacci, MD, Andrea Gallamini, MD, Robin Foà, MD, Francesco Lauria, MD
Journal: Blood
Blood (2010) 116 (21): 701.
https://doi.org/10.1182/blood.V116.21.701.701
Published: 2010
Journal Articles

Analysis of Parameters Predicting Treatment Efficacy and Outcome In Patients with Hairy Cell Leukemia (HCL) Receiving Subcutaneous Cladribine In the ICGHCL2004 Protocol (by the Italian Cooperative Group on HCL)

Francesco Forconi, MD, Emanuele Cencini, Francesco Zaja, Tamara Intermesoli, Francesca Fiore, Benedetta Puccini, Caterina Stelitano, Renato Cantaffa, Alessandro Pulsoni, Alfonso Zaccaria, Pier Luigi Zinzani, MD, PhD, Andrea Piccin, MD, Filippo Gherlinzoni, MD, Alessandro Levis, MD, Giovanni Martinelli, MD, Sara Barulli, Fortunato Morabito, MD, Ivana Pierri, Miriana Ruggeri, Alessandra Caremani, Luciano Masini, Giuseppe Polimeno, Angelo Guerrasio, Elisa Sozzi, Davide Rossi, Francesco Bertoni, Piero Galieni, Marco Gobbi, MD, Sergio Cortelazzo, Luigi Rigacci, MD, Andrea Gallamini, MD, Robin Foà, MD, Francesco Lauria, MD
Journal: Blood
Blood (2010) 116 (21): 1369.
https://doi.org/10.1182/blood.V116.21.1369.1369
Published: 2010
Journal Articles

The Dose and the duration of frontline therapy with Imatinib does not affect response to Dasatinib in Imatinib-Resistant or -intolerant patients with chronic myeloid leukemia (CML). Results from a real Life-Based Italian Multicenter retrospective study on 124 Patients.

Giuseppe Visani, Massimo Breccia, Pier Paolo Piccaluga, Antonella Gozzini, Giorgina Specchia, Enrico Montefusco, Enrica Morra, MD, Mario Annunziata, Luigiana Luciano, Andrea Camera, MD, Francesco Cavazzini, MD, Fabio Stagno, Francesco Di Raimondo, M.D., Patrizia Pregno, Francesca Pirillo, Valeria Santini, MD, Alberto Bosi, MD, Matteo Pacilli, MD, Ester Pungolino, Emilio Usala, MD, Emanuele Angelucci, MD, Monica Crugnola, Gianni Binotto, Elena Maino, Federica Loscocco, Sara Barulli, Giuseppina Nicolini, Antonio Cuneo, Roberto Latagliata, MD, Felicetto Ferrara, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1124.
https://doi.org/10.1182/blood.V114.22.1124.1124
Published: 2009
Journal Articles

Equivalent Efficacy and Lower Toxicity of Subcutaneous Cladribine at Reduced Doses (Five versus Seven Consecutive days) in Hairy Cell Leukemia: An Interim Analysis of the ICGHCL 2004 Protocol by the Italian Cooperative Group on Hcl

Francesco Forconi, Francesco Zaja, Tamara Intermesoli, Luigi Rigacci, Caterina Stelitano, Silvia Tavera, Enrico Morello, Alessandro Pulsoni, MD, Filippo Gherlinzoni, MD, Alfonso Zaccaria, Anna Baraldi, MD, Ivana Pierri, Renato Cantaffa, Giovanni Martinelli, Sara Barulli, Fortunato Morabito, MD, Pier Luigi Zinzani, MD, Mauro Spriano, Piero Galieni, Alessandra Caremani, Alice Pietrini, Emanuele Cencini, Maristella Tassi, Donatella Raspadori, Francesco Lauria
Journal: Blood
Blood (2008) 112 (11): 3174.
https://doi.org/10.1182/blood.V112.11.3174.3174
Published: 2008